In short. Polycaprolactone (PCL) biostimulators are injectable microspheres in a gel carrier that give immediate mild volume and then prompt the skin to build its own collagen, mainly type I. The gain arrives over months and commonly lasts one to two years or more, but the material cannot be dissolved if the result or a complication needs reversing.
Key points
- PCL microspheres stimulate type I collagen; the carrier gel gives only brief volume.
- It suits moderate volume loss, jawline softening, or skin laxity.
- It is not used in the lips or in very superficial skin.
- Treatment is often one session, planned conservatively because it cannot be reversed.
- Nodules and, rarely, granulomas cannot be dissolved quickly.
What is a PCL biostimulator?
Polycaprolactone is a biodegradable polymer with a long history of safe use in medical sutures and implants. In aesthetic medicine, PCL microspheres are suspended in a gel carrier and injected: the carrier gives an immediate, modest filling effect, and the microspheres stimulate the skin to produce new collagen, predominantly type I collagen, around them. Results build over months and commonly last around one to two years or more, depending on the formulation, but they are not permanent.
How the microspheres work
The carrier gel's filling effect settles over the first weeks as it is absorbed. The microspheres remain longer, acting as a scaffold that encourages fibroblasts to deposit new collagen. Over a period measured in years the body breaks the microspheres down gradually and completely, leaving the newly formed collagen network behind.
Who does it suit, and who should choose otherwise?
PCL suits people with moderate volume loss, jawline softening, or skin laxity who want longer-lasting improvement and accept a gradual onset. The contrast that matters most is with a dissolvable gel filler, which remains the more cautious starting point for someone who wants an adjustable result.
| PCL biostimulator | Dissolvable gel filler | |
|---|---|---|
| What it does | Brief carrier volume, then new collagen | Adds volume directly |
| Onset | Weeks to months | Immediate |
| Duration | Commonly one to two years or more | Shorter than PCL; depends on the product |
| Reversibility | Cannot be dissolved | Can be dissolved with an enzyme |
| Best for | Moderate volume loss, jawline softening, laxity | Lips, very superficial skin, a first adjustable trial |
| Main risks | Nodules, rarely granulomas; vascular occlusion | Injection risks; vascular occlusion |
| Wrong choice when | You want instant, fully reversible correction | You want longer-lasting change and accept gradual onset |
PCL is not used in the lips or in very superficial skin. For a first, easily adjustable experience of facial volumising, a dissolvable gel filler that can be dissolved is often the more cautious route.
What happens in a session?
Many PCL treatments achieve their goal in a single session or a small number of sessions, depending on the degree of correction needed and the individual response. Because the material cannot be dissolved with an enzyme, experienced injectors plan conservatively and prefer to review the settled result before adding more.
Our approach: we are explicit about the trade-off. PCL lasts longer than a dissolvable gel but cannot be reversed if you dislike the result or develop a complication, so we select candidates carefully, place material in the correct tissue planes, and favour conservative correction with planned review over ambitious single-session change.
Timeline: when results appear and how long they last
Swelling and possible bruising settle within days. Collagen building continues for several months, so the result at one month is not the final result. Depending on the formulation used, improvement commonly persists for one to two years or longer before maintenance is considered.
What are the risks, and when should you seek review?
Short-term effects are the usual injection-related ones: swelling, bruising, and tenderness. The material-specific risks are nodules and, rarely, granulomas, which are more likely with superficial placement or excessive volume in one area and which cannot be quickly dissolved. Management ranges from observation to injections that reduce the tissue reaction. Vascular occlusion is a rare but serious risk shared with all filler injections, and the clinic must have a clear emergency protocol.
Arrange a medical review if:
- You develop firm, persistent, or growing lumps under the skin after treatment.
- You experience severe pain, skin blanching, or a mottled, dusky colour change after injection.
- You are pregnant, breastfeeding, have an active skin infection, or have a history of abnormal scarring: discuss deferral first.
Combination and follow-up
PCL biostimulators are often combined with skin-quality treatments or used alongside a dissolvable gel filler, with the two materials chosen for different layers and purposes. A review some months after treatment, once collagen has built, is the honest point at which to judge whether more is needed. A qualified medical consultation always comes first.
Sources
- American Academy of Dermatology — information on injectable fillers and collagen stimulators
- National Institute for Health and Care Excellence — guidance on cosmetic injectables
- National Medical Products Administration (NMPA, China) — approved injectable product status
Internal links
Frequently asked questions
What is the main trade-off with PCL compared with hyaluronic acid?
PCL lasts longer, commonly one to two years or more, but it cannot be dissolved if you dislike the result or develop a complication. That is why candidates are selected carefully and conservative correction with planned review is preferred over ambitious single-session change.
When is the result of PCL treatment judged?
Not at one month. Swelling and possible bruising settle within days, but collagen building continues for several months, so the result at one month is not the final result. Review some months after treatment is the honest point at which to judge whether more is needed.
Why might hyaluronic acid be a more cautious first step?
For someone wanting a first, easily adjustable experience of facial volumising, hyaluronic acid filler can be dissolved, while PCL cannot. People with moderate volume loss, jawline softening or laxity who accept a gradual onset are the better match for PCL.
Risks & Limitations
- Vascular occlusion — a time-critical emergency in which filler blocks a blood vessel. It can cause skin loss and, rarely, blindness.
- Nodules, lumps or granuloma formation, which may need treatment or dissolution.
- Infection at the injection site.
- Asymmetry or over-correction; over-treatment is harder to correct than under-treatment.
- Migration of filler away from the intended area.
- Temporary brow or eyelid droop after botulinum toxin, which resolves as the effect wears off.
- Bruising and swelling. All injectable results are temporary and maintenance is required.
When to Seek Care
- Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky — this is a vascular emergency; seek care immediately.
- Any change in vision — seek emergency care immediately.
- Fever, spreading redness, warmth or pus at an injection site.
- A hard, painful lump that is growing.
- Drooping eyelid, difficulty swallowing, or difficulty breathing after botulinum toxin.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable safety information
- American Society of Plastic Surgeons (ASPS) — injectable guidance
- U.S. Food and Drug Administration (FDA) — approved filler and neurotoxin products
- National Medical Products Administration (NMPA, China) — approved product status
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.